Nanoformulated SOD1 ameliorates the combined NASH and alcoholassociated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver

Thiyagarajan Gopal, Narendra Kumar, Curtis Perriotte-Olson, Carol A. Casey, Terrence M. Donohue, Edward N. Harris, Geoffrey Talmon, Alexander V. Kabanov, Viswanathan Saraswathi

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Nanoformulated SOD1 ameliorates the combined NASH and alcoholassociated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver'. Together they form a unique fingerprint.

Medicine & Life Sciences